AFWM
PRME icon

Abich Financial Wealth Management’s Prime Medicine PRME Stock Holding History

Abich Financial Wealth Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$4.83K Buy
1,247
+941
+308% +$4.36K 0.01% 259
2024
Q2 		$1.57K Buy
306
+282
+1,175% +$1.71K ﹤0.01% 524
2024
Q1 		$168 Buy
+24
New +$182 ﹤0.01% 495

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Abich Financial Wealth Management's PRME Position: Q3 2024 in Review

Abich Financial Wealth Management increased its Prime Medicine (PRME) stake by 308% in Q3 2024, buying an estimated $4.36K and bringing the position to 1,247 shares worth $4.83K. The position accounts for 0.01% of the portfolio, ranked #259.

Abich Financial Wealth Management first reported a position in PRME in Q1 2024 and has held it in 3 quarters since. 116 funds tracked by Wall St. Rank hold PRME as of Q3 2024.

  • Abich Financial Wealth Management held 1,247 shares of Prime Medicine worth $4.83K as of Q3 2024.
  • Abich Financial Wealth Management bought 941 Prime Medicine shares in Q3 2024, an estimated $4.36K.
  • Prime Medicine made up 0.01% of Abich Financial Wealth Management's portfolio in Q3 2024, its #259 holding.
  • Abich Financial Wealth Management first reported a position in Prime Medicine in Q1 2024 and has held it in 3 quarters since.
  • 116 funds tracked by Wall St. Rank held Prime Medicine as of Q3 2024.

Based on Abich Financial Wealth Management's 13F filing for Q3 2024, filed 25 Oct 2024.